In what is believed to be a first-of-its-kind study to evaluate the safety of a type of immunotherapy before surgery in patients with an aggressive form of skin cancer, researchers report that the treatment eliminated pathologic evidence of cancer in nearly half of the study participants undergoing surgery. In patients whose tumors respond, this treatment approach offers the potential to reduce the extent of surgery and may also slow or eliminate tumor relapses that often occur after surgery.
- Faced with shortages, researchers combine heat and humidity to disinfect N95 masks
- 160 genes linked to brain shrinkage in study of 45,000 adults
- Ascorbic acid-mediated reactions in organic synthesis
- COVID-19 news from Annals of Internal Medicine
- Coldest Northern Hemisphere temperature, first recorded by UW, officially confirmed